Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
69
70
Next >
Checking In With Merck Stock Before Earnings
February 01, 2023
Merck will report earnings before the open Thursday, Feb. 2.
Via
Talk Markets
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
Via
InvestorPlace
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
January 30, 2023
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.
Via
Talk Markets
Where Merck & Co Stands With Analysts
January 23, 2023
Via
Benzinga
Down 14.5%, Is Pfizer Stock a Screaming Buy?
January 30, 2023
Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.
Via
The Motley Fool
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.
Via
Benzinga
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
January 27, 2023
Merck recently completed its acquisition of a California-based biotech company.
Via
The Motley Fool
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
January 26, 2023
These two healthcare giants defied the bear market last year.
Via
The Motley Fool
How I'd Invest $50,000 for Retirement If I Had to Start From Scratch
January 26, 2023
Starting with a completely clean slate free of the usual investment baggage is a liberating, insightful exercise.
Via
The Motley Fool
Earn Dividends Every Month With These 3 Stocks
January 26, 2023
Having this trio of high-quality companies in your portfolio will ensure that you collect a payout each month.
Via
The Motley Fool
My Biggest Winners Of 2022
January 25, 2023
Wondering which of my investments did the best in 2022, and how I feel about them today. Check out the video for full details.
Via
Talk Markets
Want to Collect a Dividend Every Month? Buy These 3 High-Yielding Stocks
January 25, 2023
You can keep the cash flowing into your portfolio with these above-average payouts.
Via
The Motley Fool
This Dow Jones Stock Crushed the Market in 2022 -- Can It Do It Again?
January 21, 2023
This pharmaceutical was the second-best performing Dow Jones stock in 2022 behind the energy giant Chevron.
Via
The Motley Fool
Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer
January 20, 2023
Via
Benzinga
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
January 19, 2023
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.
Via
Benzinga
Can Cannabinoid CB2 Receptor Antagonist Combined With KEYTRUDA Be Effective In Patients With Advanced Solid Tumors? These Two Companies Aim To Find Out
January 18, 2023
Teon Therapeutics a clinical-stage biopharmaceutical company targeting metabolic signaling pathways and development of G-Protein Coupled Receptor immuno-oncology therapies in difficult-to-treat...
Via
Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via
Talk Markets
Novocure Has Fallen More Than 20% Over Seven Days — Why It Fell From Grace
January 17, 2023
Shares have given back a chunk of their 69% single-day gain on a lung cancer study.
Via
Investor's Business Daily
3 Top Stocks to Buy for the Long Haul
January 14, 2023
Not too many companies are built not just to last, but to thrive in any and all market environments.
Via
The Motley Fool
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
Via
Benzinga
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories
January 11, 2023
Reuters
Via
Benzinga
Merck, Pfizer Rebuts China's Request For Further Price Cuts For COVID-19 Drugs
January 11, 2023
Merck & Co Inc (NYSE: MRK) and Pfizer Inc (NYSE: PFE) have reportedly signaled that they have not agreed to a request by the Chinese authorities for deeper price cuts for COVID-19 treatments.
Via
Benzinga
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish
January 11, 2023
2023 can be the year of biotechs after two consecutive years of negative or barely positive returns.
Via
Talk Markets
7 Hot Healthcare Stocks to Watch in 2023
January 10, 2023
Strong earnings and robust dividend payments make healthcare stocks attractive during times of uncertainty and volatility.
Via
InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2023
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
January 05, 2023
Merck has a number of efforts in the works to help avoid a Keytruda generics pitfall.
Via
Investor's Business Daily
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.